- Gemcitabine plus cisplatine and paclitaxel (GCP) in second-line treat…
Number of the records: 1  

Gemcitabine plus cisplatine and paclitaxel (GCP) in second-line treatment of germ cell tumors (GCT): a phase II study

  1. Gemcitabine plus cisplatine and paclitaxel (GCP) in second-line treatment of germ cell tumors (GCT): a phase II study / J.Mardiak, Tomáš Šálek, Z. Syčová-Milá, Jana Obertová, Z. Hlavatá, M. Mego, M. Rečková, Ivan Koza. Neoplasma Vol. 52, no. 3 (2005), p. 243-247
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.